CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Accounts Payable of $339.25 thousand for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2013-11-14
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2013-09-30 was -$58.33K, a 166.04% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2013-06-30 was $148.23K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2013-03-31 was $66.44K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2012-12-31 was -$27.13K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2012 was -$254.92K, a 341.73% decline from fiscal 2011.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2011 was $105.46K, a 41.98% decline from fiscal 2010.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2010 was $181.75K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 71 month | Increase (Decrease) in Accounts Payable 74 month | Increase (Decrease) in Accounts Payable 77 month | Increase (Decrease) in Accounts Payable 80 month | Increase (Decrease) in Accounts Payable 83 month | Increase (Decrease) in Accounts Payable 86 month | Increase (Decrease) in Accounts Payable 89 month | Increase (Decrease) in Accounts Payable 92 month | Increase (Decrease) in Accounts Payable 95 month | Increase (Decrease) in Accounts Payable 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | -$58.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $89.89K derived: sum of 2 quarters · filed 2013-11-14 | $156.33K 10-Q · filed 2013-11-14 | $129.19K derived: sum of 4 quarters · filed 2013-11-14 | $339.25K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $148.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $214.66K 10-Q · filed 2013-08-14 | $187.53K derived: sum of 3 quarters · filed 2013-08-14 | $275.86K derived: sum of 4 quarters · filed 2013-11-14 | $397.58K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $66.44K 10-Q · filed 2013-06-21 | $39.30K derived: sum of 2 quarters · filed 2013-06-21 | $127.63K derived: sum of 3 quarters · filed 2013-11-14 | -$77.80K derived: sum of 4 quarters · filed 2013-11-14 | $249.35K 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | -$27.13K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $61.20K derived: sum of 2 quarters · filed 2013-11-14 | -$144.24K derived: sum of 3 quarters · filed 2013-11-14 | -$254.92K 10-K · filed 2013-06-21 | $182.92K 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | $88.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$117.10K derived: sum of 2 quarters · filed 2013-11-14 | -$227.79K 10-Q · filed 2013-11-14 | -$294.28K derived: sum of 4 quarters · filed 2013-11-14 | $210.05K 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | -$205.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$316.12K 10-Q · filed 2013-08-14 | -$382.61K derived: sum of 3 quarters · filed 2013-08-14 | -$116.04K derived: sum of 4 quarters · filed 2013-08-14 | $121.72K 10-Q/A · filed 2012-09-10 | |||||||||
| 2012-03-31 | -$110.68K 10-Q · filed 2013-06-21 | -$177.18K derived: sum of 2 quarters · filed 2013-06-21 | $89.39K derived: sum of 3 quarters · filed 2013-06-21 | -$151.71K derived: sum of 4 quarters · filed 2013-06-21 | $327.15K 10-Q/A · filed 2012-05-15 | |||||||||
| 2011-12-31 | -$66.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $200.08K derived: sum of 2 quarters · filed 2013-06-21 | -$41.02K derived: sum of 3 quarters · filed 2013-06-21 | $105.46K 10-K · filed 2013-06-21 | $437.84K 10-K · filed 2012-04-02 | |||||||||
| 2011-09-30 | $266.57K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | $25.47K derived: sum of 2 quarters · filed 2013-06-21 | $171.95K 10-Q · filed 2013-06-21 | -$87.22K derived: sum of 4 quarters · filed 2013-06-21 | $504.33K 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | -$241.10K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-10 | -$94.62K 10-Q/A · filed 2012-09-10 | -$353.79K derived: sum of 3 quarters · filed 2012-09-10 | $83.73K derived: sum of 4 quarters · filed 2012-09-10 | $237.76K 10-Q · filed 2011-08-15 | |||||||||
| 2011-03-31 | $146.48K 10-Q/A · filed 2012-05-15 | -$112.69K derived: sum of 2 quarters · filed 2012-05-15 | $324.83K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||
| 2010-12-31 | -$259.17K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $178.35K derived: sum of 2 quarters · filed 2012-04-02 | $181.75K 10-K · filed 2012-04-02 | |||||||||||
| 2010-09-30 | $437.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $440.93K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $3.40K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |